Andrew B Mendlowitz
Overview
Explore the profile of Andrew B Mendlowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masterman C, Mendlowitz A, Capraru C, Campbell K, Eastabrook G, Yudin M, et al.
BMC Public Health
. 2024 Sep;
24(1):2660.
PMID: 39342214
Background: Stigma is a complex social phenomenon that leads to marginalization and influences the course of illness. In the context of hepatitis C virus (HCV), stigma is a well-documented barrier...
2.
Fattouh R, Boissinot K, Jeong E, Mendlowitz A, Sjaarda C, Wong H, et al.
J Infect Dis
. 2024 Mar;
229(Supplement_2):S156-S162.
PMID: 38531075
Background: In 2022, the global dissemination of mpox virus (MPXV) outside endemic regions prompted the expansion of diagnostic testing worldwide. This study assesses the performance characteristics of 5 real-time polymerase...
3.
Mendlowitz A, Mandel E, Capraru C, Hansen B, Wong D, Feld J, et al.
Can Liver J
. 2024 Mar;
7(1):28-39.
PMID: 38505784
Background: Migrants from hepatitis B virus (HBV) endemic regions are at high risk of having chronic infection. Despite this, HBV knowledge and awareness programming, and low-barrier screening methods such as...
4.
Tian F, Forouzannia F, Feng Z, Biondi M, Mendlowitz A, Feld J, et al.
Hepatology
. 2024 Mar;
80(2):440-450.
PMID: 38478751
Background And Aims: Despite the availability of highly effective direct-acting antiviral therapy, chronic hepatitis C (CHC) continues to cause a major public health burden. In many high-income countries, treatment rates...
5.
Biondi M, Lynch K, Floriancic N, Cronin K, Marchand-Austin A, Mendlowitz A, et al.
J Obstet Gynaecol Can
. 2024 Mar;
46(6):102423.
PMID: 38452927
Objectives: International infectious disease/obstetrical societies have recently recommended universal hepatitis C virus (HCV) prenatal screening and these same recommendations are forthcoming in Canada. At present, there is no formal analysis...
6.
Atif J, Udhesister S, Abdelnabi M, Dsouza S, Hung J, Edgar R, et al.
Can Liver J
. 2023 Dec;
5(4):441-444.
PMID: 38144406
No abstract available.
7.
Zeitouny S, Cheung D, Bremner K, Pataky R, Pequeno P, Matelski J, et al.
PLoS One
. 2023 Sep;
18(9):e0290646.
PMID: 37682823
Introduction: The aim of our study was to assess the initial impact of COVID-19 on total publicly-funded direct healthcare costs and health services use in two Canadian provinces, Ontario and...
8.
Mendlowitz A, Bremner K, Krahn M, Walker J, Wong W, Sander B, et al.
CMAJ
. 2023 Apr;
195(14):E499-E512.
PMID: 37040993
Background: As First Nations Peoples are a priority focus of Canada's commitment to eliminating hepatitis C virus (HCV) as a public health threat, understanding individuals' progression from diagnosis to cure...
9.
Mendlowitz A, Bremner K, Feld J, Jones L, Hill E, Antone E, et al.
Can Liver J
. 2023 Mar;
6(1):46-55.
PMID: 36908573
Administrative health data provide a rich and powerful tool for health services research. Partnership between researchers and the Ontario First Nations HIV/AIDS Education Circle (OFNHAEC) allowed for comprehensive analyses of...
10.
Mendlowitz A, Feld J, Biondi M
Viruses
. 2023 Jan;
15(1).
PMID: 36680130
In 2016, the World Health Organization released a plan to eliminate viral hepatitis as a public health threat by 2030. For Canada to achieve the recommended decreases in HBV- and...